Wolff Wiese Magana’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.7K Buy
655
+1
+0.2% +$57 0.02% 270
2026
Q1
$39.7K Sell
654
-12
-2% -$700 0.02% 238
2025
Q4
$35.9K Buy
666
+1
+0.2% +$48 0.02% 246
2025
Q3
$30K Sell
665
-39
-6% -$1.82K 0.02% 266
2025
Q2
$32.6K Buy
704
+44
+7% +$2.16K 0.02% 239
2025
Q1
$40.3K Buy
660
+50
+8% +$2.91K 0.03% 210
2024
Q4
$34.5K Sell
610
-250
-29% -$14K 0.02% 232
2024
Q3
$44.5K Sell
860
-36
-4% -$1.69K 0.03% 199
2024
Q2
$37.2K Sell
896
-97
-10% -$4.34K 0.03% 188
2024
Q1
$53.9K Sell
993
-127
-11% -$6.47K 0.05% 138
2023
Q4
$57.5K Sell
1,120
-40
-3% -$2.1K 0.05% 131
2023
Q3
$67.3K Sell
1,160
-7
-0.6% -$429 0.05% 163
2023
Q2
$74.6K Buy
1,167
+30
+3% +$2.01K 0.06% 157
2023
Q1
$78.8K Sell
1,137
-113
-9% -$7.97K 0.06% 150
2022
Q4
$89.9K Sell
1,250
-16
-1% -$1.21K 0.08% 142
2022
Q3
$90K Sell
1,266
-78
-6% -$5.66K 0.07% 177
2022
Q2
$104K Sell
1,344
-38,838
-97% -$2.96M 0.08% 170
2022
Q1
$2.93M Buy
40,182
+211
+0.5% +$14.2K 1.97% 6
2021
Q4
$2.49M Buy
39,971
+3,102
+8% +$182K 1.61% 12
2021
Q3
$2.18M Buy
36,869
+6,735
+22% +$444K 1.54% 15
2021
Q2
$2.01M Sell
30,134
-327
-1% -$21.3K 1.44% 14
2021
Q1
$1.92M Buy
30,461
+1,876
+7% +$117K 1.5% 14
2020
Q4
$1.77M Buy
+28,585
New +$1.76M 1.5% 12

Other funds holding BMY

Wolff Wiese Magana's BMY Position: Q2 2026 in Review

Wolff Wiese Magana increased its Bristol-Myers Squibb (BMY) stake by 0.15% in Q2 2026, buying an estimated $57 and bringing the position to 655 shares worth $37.7K. The position accounts for 0.02% of the portfolio, ranked #270.

Wolff Wiese Magana first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.93M in Q1 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wolff Wiese Magana held 655 shares of Bristol-Myers Squibb worth $37.7K as of Q2 2026.
  • Wolff Wiese Magana bought 1 Bristol-Myers Squibb share in Q2 2026, an estimated $57.
  • Bristol-Myers Squibb made up 0.02% of Wolff Wiese Magana's portfolio in Q2 2026, its #270 holding.
  • Wolff Wiese Magana first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Bristol-Myers Squibb position peaked at $2.93M in Q1 2022.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.